Pineda J A, Murdock G L, Watson R J, Warren J C
Department of Obstetrics and Gynecology, Washington University School of Medicine, St Louis 63110.
J Steroid Biochem Mol Biol. 1990 Sep;37(1):65-70. doi: 10.1016/0960-0760(90)90373-s.
We have previously shown that human placental estradiol-17 beta dehydrogenase (EC 1.1.1.62; 17 beta-EDH) catalyzes the conversion of estradiol-17 beta to estrone and stereospecifically reduces NAD+ to [4-pro-S]NADH, [( 4-B]NADH). Subsequently, this enzyme was found to reduce the ketone function at C-20 of progesterone, and evidence indicates that both activities reside at the same active site. This study was done to further elucidate spatial arrangements of cofactor and the 21-carbon substrate as they bind at the active site. The cofactor, [4B-3H]NADPH, was generated with homogeneous 17 beta-EDH from term human placenta, utilizing [17 alpha-3H]estradiol-17 beta and NADP+. The resulting [4B-3H]NADPH was then purified by ion exchange chromatography and was separately incubated (24.4 microM) with a large molar excess of progesterone (150 microM) as substrate in the presence of the enzyme. Following incubation, the steroid reactants and products were extracted, separated by high-performance liquid chromatography and quantitated as to mass and tritium content. Oxidized and reduced cofactor were separated by ion-exchange chromatography and similarly quantitated. In all incubations, equimolar amounts of 20 alpha-hydroxy-4-pregnen-3-one (20 alpha-OHP) and NADP+ were obtained. Radioactivity was stoichiometrically transferred from [4B-3H]NADPH to the steroid product [( 3H]20 alpha-OHP). These results further substantiate a single active site for both 17 beta- and 20 alpha-dehydrogenation enzyme activities. In addition, the enzyme is B-side specific, catalyzing the transfer of the 4B-hydrogen from the dihydronicotinamide moiety of the cofactor, for both C-18 and C-21 steroid substrates. Since the 20 alpha-dehydrogenation by other enzyme sources has always been demonstrated to be an A-side specific reaction, this observation represents an important exception to the Alworth-Bentley rules of enzyme stereospecificity.
我们之前已经表明,人胎盘雌二醇 - 17β脱氢酶(EC 1.1.1.62;17β - EDH)催化雌二醇 - 17β转化为雌酮,并立体特异性地将NAD⁺还原为[4 - pro - S]NADH,即[(4 - B]NADH)。随后,发现该酶还能还原孕酮C - 20位的酮基,且有证据表明这两种活性位于同一活性位点。本研究旨在进一步阐明辅因子和21碳底物在活性位点结合时的空间排列。利用[17α - ³H]雌二醇 - 17β和NADP⁺,从足月人胎盘中用均一的17β - EDH生成辅因子[4B - ³H]NADPH。然后通过离子交换色谱法纯化得到的[4B - ³H]NADPH,并在酶存在的情况下,将其与大摩尔过量的孕酮(150 μM)作为底物分别孵育(24.4 μM)。孵育后,提取类固醇反应物和产物,通过高效液相色谱法分离,并对质量和氚含量进行定量。通过离子交换色谱法分离氧化型和还原型辅因子,并进行类似的定量。在所有孵育中,均获得了等摩尔量的20α - 羟基 - 4 - 孕烯 - 3 - 酮(20α - OHP)和NADP⁺。放射性化学计量地从[4B - ³H]NADPH转移到类固醇产物[(³H]20α - OHP)。这些结果进一步证实了17β - 和20α - 脱氢酶活性具有单一活性位点。此外,该酶对B侧具有特异性,对于C - 18和C - 21类固醇底物,催化辅因子二氢烟酰胺部分的4B - 氢的转移。由于其他酶源的20α - 脱氢反应一直被证明是A侧特异性反应,这一观察结果代表了对阿尔沃思 - 本特利酶立体特异性规则的一个重要例外。